Although gastrointestinal stromal tumor, or GIST, is a rare type of cancer, between 4,000 and 6,000 people are diagnosed with ...

Celldex has stopped development of barzolvolimab in eosinophilic esophagitis (EoE) despite meeting its primary endpoint in a ...

Endoscopy has long been viewed as the gold standard for diagnosing issues in the gastrointestinal tract, but the capsule ...

New research found that gastrointestinal cancer rates are on the rise among younger people. While colorectal cancer is the ...

The study, published 20 November in Nature, details how the team harmonized over 25 single-cell datasets of the human gastrointestinal (GI) tract to create the world's largest freely-available ...

Study met primary endpoint demonstrating barzolvolimab’s ability to potently deplete mast cells in the gastrointestinal tractProfound mast cell depletion did not result in improved clinical outcomes p ...

Cell-based therapies, which harness the power of the immune system to fight cancer, represent one of the most promising developments. Since the first approval of tisagenlecleucel, a CD19-directed ...

The cells, known as gut metaplastic cells, are known to be involved in healing the stomach lining. However, the team discovered that these cells contained genetic similarities to other GI cells ...

The cells, known as gut metaplastic cells, are known to be involved in healing the stomach lining. However, the team discovered that these cells contained genetic similarities to other GI cells ...